Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
4(36%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
9%
Ph not_applicable
3
27%
Ph phase_2
4
36%
Ph phase_3
2
18%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Recruiting4
Completed4
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (10.0%)
Phase 24 (40.0%)
Phase 32 (20.0%)
N/A3 (30.0%)

Trials by Status

unknown218%
recruiting436%
withdrawn19%
completed436%

Recent Activity

4 active trials
Showing 5 of 11
withdrawnphase_2

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

NCT06866951
recruitingnot_applicable

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

NCT05421650
recruitingnot_applicable

Toripalimab Combined With Definitive CCRT for LACC Patients

NCT06256224
recruitingphase_3

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

NCT05173272
recruitingnot_applicable

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

NCT04409860
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06866951Phase 2

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

Withdrawn
NCT05421650Not Applicable

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Recruiting
NCT06256224Not Applicable

Toripalimab Combined With Definitive CCRT for LACC Patients

Recruiting
NCT05173272Phase 3

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

Recruiting
NCT04409860Not Applicable

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

Recruiting
NCT03008148Phase 2

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Unknown
NCT02425605Phase 2

Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma

Completed
NCT01395667Phase 1

Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX

Completed
NCT02604472

Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients

Completed
NCT00201396Phase 3

A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

Completed
NCT00620269Phase 2

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

Unknown

All 11 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
11